Key facts
- It has raised $64.6M; the latest was Debt - General ($23.1M) in Jul 2025.
- Notable investors include MedTech Innovator, Bundesministerium für Bildung und Forschung, Cochlear, European Innovation Council (Belgium), Horizon Europe.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Precisis
- ·The full record, as it builds
Funding rounds
No funding rounds for Precisis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Precisis
Developer of a medical device designed to offer effective epilepsy treatment and improve quality of life. The company offers a brain-computer interface device that individualizes brain stimulation and is surgically placed beneath the scalp over the epileptic origin with anatomical precision, enabling patients with epilepsy a deep and focused stimulation of the brain, without direct contact or skull penetration.
- Sector
- Healthcare
- HQ
- Heidelberg, Germany
- Founded
- 2002
- Employees
- 41
- Website
- precisis.de/
- Ownership
- Privately Held (backing)
Precisis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Precisis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Precisis in its N-PORT filings yet. We sweep new filings monthly.